Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Pharma Grade Pin Mill

April 14, 2015 11:49 am | by Munson Machinery | Product Releases | Comments

The CIM-18-S316 Pin Mill from Munson Machinery grinds friable powders, flakes and granules into controlled particle sizes ranging from coarse to fine.

Recipharm Equity Investment in Synthonics

April 14, 2015 11:43 am | by Recipharm | News | Comments

$2.0 million of preferred stock will be purchased upon Synthonics’ achievement of certain milestones, which could be expected during 2016.

TOPICS:

Galena Hits Crucial Stage in Immunotherapy Trial

April 14, 2015 11:37 am | by Galena Biopharma | News | Comments

Galena Biopharma, Inc. completed enrollment in the NeuVax Phase 3 PRESENT clinical trial. NeuVax is a HER2-directed cancer immunotherapy.

TOPICS:
Advertisement

Rentschler Biotechnologie Expands Biopharm Capabilities

April 14, 2015 11:28 am | by GE Healthcare | News | Comments

GE Healthcare Life Sciences and Rentschler Biotechnologie GmbH announced the expansion of Rentschler’s biopharmaceutical manufacturing capabilities.

TOPICS:

Ventana and Astellas Work on Targeted Cancer Treatments

April 14, 2015 11:09 am | by Ventana Medical Systems, Inc. | News | Comments

Ventana, a member of the Roche Group, announced it has entered into a master collaboration agreement with Astellas Pharma Inc.

TOPICS:

Australia to Withhold Payments from Parents Against Vaccine

April 14, 2015 10:54 am | by Rod McGuirk, Associated Press | News | Comments

The crackdown comes as similar moves to limit vaccination waivers in the United States have proved to be deeply divisive.

TOPICS:

Norovirus Sickens 200 on Cruise Ships

April 14, 2015 10:49 am | by The Associated Press | News | Comments

Federal health officials say about 200 people have come down with vomiting and diarrhea aboard two San Diego-bound cruise ships.

TOPICS:

Actavis: No Apologies for Seeking Alzheimer's Drug Profits

April 14, 2015 10:45 am | by Larry Neumeister, Associated Press | News | Comments

A lawyer for Actavis urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits.

TOPICS:
Advertisement

SD30 Attritor for Reactive Milling

April 13, 2015 4:05 pm | by Union Process | Product Releases | Comments

Union Process, Inc. has manufactured an SD30 dry grinding Attritor for a customer who is using the mill for reactive milling.

Specialty, Generic Drug Costs Drive Medicaid Costs Up

April 13, 2015 4:01 pm | by MARIE FRENCH, Associated Press | News | Comments

The high cost of a drug used to treat Medicaid patients with hepatitis C drew scrutiny from lawmakers earlier this year, but other drugs are also driving up the state's costs and likely will continue to do so for several years, government data reveals.

TOPICS:

FDA Confirms Change of Ownership of 23 US Generic Drugs

April 13, 2015 3:54 pm | by PR Newswire | News | Comments

IDT Australia Limited announced that the U.S. Food and Drug Administration (FDA) has confirmed receipt of the change of ownership letters formally transferring ownership of the 23 generic drug products to IDT.

TOPICS:

Cipher Pharmaceuticals to Acquire INNOCUTIS

April 13, 2015 3:26 pm | by PR Newswire | News | Comments

Cipher Pharmaceuticals Inc. announced it has acquired INNOCUTIS Holdings LLC, a privately held specialty dermatology company, for $45.5 million in cash.

TOPICS:

ND Measure Allows Patients to Try Experimental Treatments

April 13, 2015 3:17 pm | by The Associated Press | News | Comments

North Dakota's Legislature has passed a measure that gives patients the chance to try experimental drugs that haven't gotten final approval for general use from the U.S. Food and Drug Administration.

TOPICS:

Hi-Tech Pharmaceuticals To Acquire Advanced Pharmaceuticals and Nutritionals

April 13, 2015 3:13 pm | by PRNewswire | News | Comments

The companies said the acquisition creates a top-tiered global OTC pharmaceutical and nutraceutical company.

TOPICS:

Roche Acquires CAPP Medical

April 13, 2015 1:33 pm | by Roche | News | Comments

Roche has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading